W H de Vos Tot Nederveen Cappel
Overview
Explore the profile of W H de Vos Tot Nederveen Cappel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huisman J, Schoenaker I, Brohet R, de Vos Tot Nederveen Cappel W, Beets G, van Westreenen H
Ann Surg Oncol
. 2021 Jan;
28(7):4064-4065.
PMID: 33423176
No abstract available.
2.
Huisman J, Schoenaker I, Brohet R, Reerink O, van der Sluis H, Moll F, et al.
Ann Surg Oncol
. 2020 Nov;
28(5):2811-2818.
PMID: 33170456
Background: Pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) is found in 15-20% of patients with locally advanced rectal cancer. A watch-and-wait (W&W) strategy has been introduced as an alternative...
3.
Steenhuis E, Schoenaker I, de Groot J, Fiebrich H, de Graaf J, Brohet R, et al.
Eur J Surg Oncol
. 2020 Aug;
46(11):2068-2073.
PMID: 32778485
Background: Colorectal carcinoma (CRC) has a worldwide incidence of 1.4 million patients and a large share in cancer-related mortality. After curative treatment, the risk of recurrence is 30-65%. Early detection...
4.
Huisman J, van Westreenen H, Van der Wouden E, Vasen H, de Graaf E, Doornebosch P, et al.
Tech Coloproctol
. 2019 Jul;
23(6):551-557.
PMID: 31338710
Background: Anastomotic leak after rectal surgery is reported in 9% (range 3-28%) of patients. The aim of our study was to evaluate the effectiveness of endosponge therapy for anastomotic. Endpoints...
5.
Brands H, Lupton S, Kate M, de Vos Tot Nederveen Cappel W
Neth J Med
. 2018 Mar;
76(2):92.
PMID: 29515013
No abstract available.
6.
Leicher L, Lammertink M, Offerman S, Morreau H, de Jong M, de Groot J, et al.
Scand J Gastroenterol
. 2017 Nov;
53(5):632-636.
PMID: 29161904
Introduction: Mismatch repair deficiency (dMMR) can be found in Lynch syndrome (LS)-associated colorectal carcinoma and in 15% of sporadic colorectal cancer (CRC). Outcome of MMR-deficiency testing is important for surgical...
7.
Bronsgeest K, Huisman J, Langers A, Boonstra J, Schenk B, de Vos Tot Nederveen Cappel W, et al.
Int J Colorectal Dis
. 2017 Sep;
32(12):1711-1717.
PMID: 28884225
Background: Endoscopic mucosal resection (EMR) has been proven to be safe and effective for the treatment of colorectal adenomas. However, data are limited on the safety of this technique for...
8.
Backes Y, de Vos Tot Nederveen Cappel W, van Bergeijk J, Ter Borg F, Schwartz M, Spanier B, et al.
Am J Gastroenterol
. 2017 Mar;
112(5):785-796.
PMID: 28323275
Objectives: The decision to perform secondary surgery after endoscopic resection of T1 colorectal cancer (CRC) depends on the risk of lymph node metastasis and the risk of incomplete resection. We...
9.
Overwater A, Kessels K, Elias S, Backes Y, Spanier B, Seerden T, et al.
Gut
. 2016 Nov;
67(2):284-290.
PMID: 27811313
Objective: It is difficult to predict the presence of histological risk factors for lymph node metastasis (LNM) before endoscopic treatment of T1 colorectal cancer (CRC). Therefore, endoscopic therapy is propagated...
10.
Huisman J, Leicher L, de Boer E, van Westreenen H, de Groot J, Holman F, et al.
Int J Colorectal Dis
. 2016 Oct;
32(3):367-373.
PMID: 27783161
Background: In patients with stenosing colorectal cancer (CRC), visualization of the entire colon prior to surgery is recommended to exclude synchronous tumors. Therefore, most centers combine computed tomographic colonography (CTC)...